Should You Avoid ACADIA Pharmaceuticals Inc. (ACAD)?
To most traders, hedge funds are seen as unimportant, outdated investment tools of the past.
Halozyme Therapeutics Inc. (HALO)
Market is closed
News
- First
- << Previous
- 81 - 87
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks.
ACADIA Pharmaceuticals Inc. (ACAD): Insiders Are Dumping, Should You?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) was in 12 hedge funds' portfolio at the end of the fourth quarter of 2012.
Halozyme Therapeutics, Inc. (HALO): Are Hedge Funds Right About This Stock? - Merrimack Pharmaceuticals Inc (MACK), TESARO Inc (TSRO)
To most stock holders, hedge funds are perceived as worthless, old financial vehicles of years past.
3 Horrendous Health-Care Stocks This Week: Rigel Pharmaceuticals, Inc. (RIGL), Achillion Pharmaceuticals, Inc. (ACHN)
The Motley Fool's annual April Fools' Day joke this year focused on the "hugest bubble in history" that is set to explode. For some health-care stocks, though, the bubble popping was no joke.
Micron Technology, Inc. (MU), Pfizer Inc. (PFE): Whoa! These Stocks Outpaced the Dow
The Dow Jones Industrial Average rose by 90 points on Friday -- the exact amount it fell the day before -- on hopes that a deal between the European Union and Cyprus would get hammered out that wouldn...
3 Horrendous Health-Care Stocks This Week: Herbalife Ltd. (HLF), Celsion Corporation (CLSN) and More
It's hard to believe, but the first month of 2013 has already flown by. We ended January the same way we started it: with plenty of health-care stocks crashing.
- First
- << Previous
- 81 - 87
Billionaire Hedge Funds
